Target regimen profiles for tuberculosis treatment, 2023 update

Download or Read eBook Target regimen profiles for tuberculosis treatment, 2023 update PDF written by World Health Organization and published by World Health Organization. This book was released on 2023-11-01 with total page 92 pages. Available in PDF, EPUB and Kindle.
Target regimen profiles for tuberculosis treatment, 2023 update
Author :
Publisher : World Health Organization
Total Pages : 92
Release :
ISBN-10 : 9789240081512
ISBN-13 : 9240081518
Rating : 4/5 (12 Downloads)

Book Synopsis Target regimen profiles for tuberculosis treatment, 2023 update by : World Health Organization

Book excerpt:


Target regimen profiles for tuberculosis treatment, 2023 update Related Books

Target regimen profiles for tuberculosis treatment, 2023 update
Language: en
Pages: 92
Authors: World Health Organization
Categories: Medical
Type: BOOK - Published: 2023-11-01 - Publisher: World Health Organization

DOWNLOAD EBOOK

Treatment of Tuberculosis
Language: en
Pages: 60
Authors: World Health Organization
Categories: Medical
Type: BOOK - Published: 1993 - Publisher:

DOWNLOAD EBOOK

Disease Control Priorities, Third Edition (Volume 6)
Language: en
Pages: 1027
Authors: King K. Holmes
Categories: Medical
Type: BOOK - Published: 2017-11-06 - Publisher: World Bank Publications

DOWNLOAD EBOOK

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimic
Target product profiles for tests for tuberculosis treatment monitoring and optimization
Language: en
Pages: 50
Authors: World Health Organization
Categories: Medical
Type: BOOK - Published: 2023-10-17 - Publisher: World Health Organization

DOWNLOAD EBOOK

WHO consolidated guidelines on drug-resistant tuberculosis treatment
Language: en
Pages: 0
Authors: World Health Organization
Categories: Medical
Type: BOOK - Published: 2018-11-07 - Publisher: World Health Organization

DOWNLOAD EBOOK

Tuberculosis (TB) strains with drug resistance (DR-TB) are more difficult to treat than drug-susceptible ones, and threaten global progress towards the targets